Patient recruitment for tigilanol tiglate trials in USA completed
January, 2018 Update
In late December, we finalised patient recruitment for the US tigilanol tiglate mast cell tumour veterinary pivotal field efficacy study with the required 120 dogs now recruited.
This is a great milestone for the company on the path to product registration in the US and Europe. The final report for the study is expected in Q3 2018.